- Home
- CCU vs HRMY Comparison
CCU vs HRMY Comparison
Compare CCU & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- HRMY
- Stock Information
- Founded
- CCU 1850
- HRMY 2017
- Country
- CCU Chile
- HRMY United States
- Employees
- CCU N/A
- HRMY N/A
- Industry
- CCU Beverages (Production/Distribution)
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- HRMY Health Care
- Exchange
- CCU Nasdaq
- HRMY Nasdaq
- Market Cap
- CCU 2.0B
- HRMY 2.0B
- IPO Year
- CCU 1992
- HRMY 2020
- Fundamental
- Price
- CCU $11.66
- HRMY $39.05
- Analyst Decision
- CCU Strong Sell
- HRMY Strong Buy
- Analyst Count
- CCU 2
- HRMY 8
- Target Price
- CCU $9.70
- HRMY $55.00
- AVG Volume (30 Days)
- CCU 176.8K
- HRMY 593.9K
- Earning Date
- CCU 02-25-2025
- HRMY 02-20-2025
- Dividend Yield
- CCU 1.48%
- HRMY N/A
- EPS Growth
- CCU 16.02
- HRMY N/A
- EPS
- CCU 0.39
- HRMY 2.11
- Revenue
- CCU $2,795,960,314.00
- HRMY $681,879,000.00
- Revenue This Year
- CCU $7.56
- HRMY $24.79
- Revenue Next Year
- CCU $6.29
- HRMY $19.00
- P/E Ratio
- CCU $14.97
- HRMY $18.55
- Revenue Growth
- CCU N/A
- HRMY 25.83
- 52 Week Low
- CCU $10.00
- HRMY $28.14
- 52 Week High
- CCU $13.74
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- CCU 56.20
- HRMY 71.30
- Support Level
- CCU $11.41
- HRMY $35.72
- Resistance Level
- CCU $11.82
- HRMY $37.16
- Average True Range (ATR)
- CCU 0.24
- HRMY 1.29
- MACD
- CCU 0.01
- HRMY 0.48
- Stochastic Oscillator
- CCU 78.95
- HRMY 92.25
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.